Cargando…

Beyond Colonoscopy: Exploring New Cell Surface Biomarkers for Detection of Early, Heterogenous Colorectal Lesions

Colorectal cancer (CRC) is the third leading cause of cancer-related deaths among both men and women in the United States. Early detection and surgical removal of high-risk lesions in the colon can prevent disease from developing and spreading. Despite implementation of programs aimed at early detec...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramezani, Saleh, Parkhideh, Arianna, Bhattacharya, Pratip K., Farach-Carson, Mary C., Harrington, Daniel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287259/
https://www.ncbi.nlm.nih.gov/pubmed/34290978
http://dx.doi.org/10.3389/fonc.2021.657701
_version_ 1783723877800607744
author Ramezani, Saleh
Parkhideh, Arianna
Bhattacharya, Pratip K.
Farach-Carson, Mary C.
Harrington, Daniel A.
author_facet Ramezani, Saleh
Parkhideh, Arianna
Bhattacharya, Pratip K.
Farach-Carson, Mary C.
Harrington, Daniel A.
author_sort Ramezani, Saleh
collection PubMed
description Colorectal cancer (CRC) is the third leading cause of cancer-related deaths among both men and women in the United States. Early detection and surgical removal of high-risk lesions in the colon can prevent disease from developing and spreading. Despite implementation of programs aimed at early detection, screening colonoscopies fail to detect a fraction of potentially aggressive colorectal lesions because of their location or nonobvious morphology. Optical colonoscopies, while highly effective, rely on direct visualization to detect changes on the surface mucosa that are consistent with dysplasia. Recent advances in endoscopy techniques and molecular imaging permit microscale visualization of the colonic mucosa. These technologies can be combined with various molecular probes that recognize and target heterogenous lesion surfaces to achieve early, real-time, and potentially non-invasive, detection of pre-cancerous lesions. The primary goal of this review is to contextualize existing and emergent CRC surface biomarkers and assess each’s potential as a candidate marker for early marker-based detection of CRC lesions. CRC markers that we include were stratified by the level of support gleaned from peer-reviewed publications, abstracts, and databases of both CRC and other cancers. The selected biomarkers, accessible on the cell surface and preferably on the luminal surface of the colon tissue, are organized into three categories: (1) established biomarkers (those with considerable data and high confidence), (2) emerging biomarkers (those with increasing research interest but with less supporting data), and (3) novel candidates (those with very recent data, and/or supportive evidence from other tissue systems). We also present an overview of recent advances in imaging techniques useful for visual detection of surface biomarkers, and discuss the ease with which these methods can be combined with microscopic visualization.
format Online
Article
Text
id pubmed-8287259
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82872592021-07-20 Beyond Colonoscopy: Exploring New Cell Surface Biomarkers for Detection of Early, Heterogenous Colorectal Lesions Ramezani, Saleh Parkhideh, Arianna Bhattacharya, Pratip K. Farach-Carson, Mary C. Harrington, Daniel A. Front Oncol Oncology Colorectal cancer (CRC) is the third leading cause of cancer-related deaths among both men and women in the United States. Early detection and surgical removal of high-risk lesions in the colon can prevent disease from developing and spreading. Despite implementation of programs aimed at early detection, screening colonoscopies fail to detect a fraction of potentially aggressive colorectal lesions because of their location or nonobvious morphology. Optical colonoscopies, while highly effective, rely on direct visualization to detect changes on the surface mucosa that are consistent with dysplasia. Recent advances in endoscopy techniques and molecular imaging permit microscale visualization of the colonic mucosa. These technologies can be combined with various molecular probes that recognize and target heterogenous lesion surfaces to achieve early, real-time, and potentially non-invasive, detection of pre-cancerous lesions. The primary goal of this review is to contextualize existing and emergent CRC surface biomarkers and assess each’s potential as a candidate marker for early marker-based detection of CRC lesions. CRC markers that we include were stratified by the level of support gleaned from peer-reviewed publications, abstracts, and databases of both CRC and other cancers. The selected biomarkers, accessible on the cell surface and preferably on the luminal surface of the colon tissue, are organized into three categories: (1) established biomarkers (those with considerable data and high confidence), (2) emerging biomarkers (those with increasing research interest but with less supporting data), and (3) novel candidates (those with very recent data, and/or supportive evidence from other tissue systems). We also present an overview of recent advances in imaging techniques useful for visual detection of surface biomarkers, and discuss the ease with which these methods can be combined with microscopic visualization. Frontiers Media S.A. 2021-07-05 /pmc/articles/PMC8287259/ /pubmed/34290978 http://dx.doi.org/10.3389/fonc.2021.657701 Text en Copyright © 2021 Ramezani, Parkhideh, Bhattacharya, Farach-Carson and Harrington https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Ramezani, Saleh
Parkhideh, Arianna
Bhattacharya, Pratip K.
Farach-Carson, Mary C.
Harrington, Daniel A.
Beyond Colonoscopy: Exploring New Cell Surface Biomarkers for Detection of Early, Heterogenous Colorectal Lesions
title Beyond Colonoscopy: Exploring New Cell Surface Biomarkers for Detection of Early, Heterogenous Colorectal Lesions
title_full Beyond Colonoscopy: Exploring New Cell Surface Biomarkers for Detection of Early, Heterogenous Colorectal Lesions
title_fullStr Beyond Colonoscopy: Exploring New Cell Surface Biomarkers for Detection of Early, Heterogenous Colorectal Lesions
title_full_unstemmed Beyond Colonoscopy: Exploring New Cell Surface Biomarkers for Detection of Early, Heterogenous Colorectal Lesions
title_short Beyond Colonoscopy: Exploring New Cell Surface Biomarkers for Detection of Early, Heterogenous Colorectal Lesions
title_sort beyond colonoscopy: exploring new cell surface biomarkers for detection of early, heterogenous colorectal lesions
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287259/
https://www.ncbi.nlm.nih.gov/pubmed/34290978
http://dx.doi.org/10.3389/fonc.2021.657701
work_keys_str_mv AT ramezanisaleh beyondcolonoscopyexploringnewcellsurfacebiomarkersfordetectionofearlyheterogenouscolorectallesions
AT parkhideharianna beyondcolonoscopyexploringnewcellsurfacebiomarkersfordetectionofearlyheterogenouscolorectallesions
AT bhattacharyapratipk beyondcolonoscopyexploringnewcellsurfacebiomarkersfordetectionofearlyheterogenouscolorectallesions
AT farachcarsonmaryc beyondcolonoscopyexploringnewcellsurfacebiomarkersfordetectionofearlyheterogenouscolorectallesions
AT harringtondaniela beyondcolonoscopyexploringnewcellsurfacebiomarkersfordetectionofearlyheterogenouscolorectallesions